Kaitai Capital
135
10M
109
9.00
24
0.19
4
- Stages of investment
- Areas of investment
Summary
Kaitai Capital is the famous VC, which was founded in 2009. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Hangzhou.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Kaitai Capital, startups are often financed by Viva BioInnovator, TF Capital, Nanjing Jiangbei New District Service Trade Innovation Development Fund. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Xiamen Meiya Wutong Investment Management, Tekla Capital Management. In the next rounds fund is usually obtained by Vertex Ventures China, Source Code Capital, Photon Fund.
The high activity for fund was in 2018. The real fund results show that this VC is 48 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline CARsgen Therapeutics, Amphivena Therapeutics, Tekeluo Biotech For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has exact preference in some founders of portfolio startups.
Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 135
- Lead investments
- 24
- Exits
- 4
- Rounds per year
- 9.00
- Follow on index
- 0.19
- Investments by industry
- Biotechnology (48)
- Health Care (40)
- Pharmaceutical (26)
- Medical (19)
- Therapeutics (18) Show 100 more
- Investments by region
-
- China (101)
- United States (28)
- United Kingdom (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.67
- Avg. company exit year
- 12
- Avg. multiplicator
- 4.52
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Exegenesis Bio | 03 Aug 2020 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | United States, Pennsylvania | |
| TianTi Biotherapeutics | 20 Dec 2021 | Early Stage Venture | 15M | United States, Massachusetts, Woburn |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.